0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
EUR$4,995USDGBP
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,995USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
EUR$4,500USDGBP
From
EUR$3,995USDGBP
From
EUR$3,750USDGBP
From
EUR$2,500USDGBP
Inhalation Anesthesia Market Report 2025 - Product Thumbnail Image

Inhalation Anesthesia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more